UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2023
Commission File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
10 HaNechoshet Street Tel-Aviv, 6971072, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
EXPLANATORY NOTE
On September 28, 2023, Medigus
Ltd. issued a press release titled: “Medigus to Acquire 60% Interest of Commercial Property in Miami.” A copy of this press
release is furnished herewith as Exhibit 99.1
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
MEDIGUS LTD. |
|
|
|
Date: September 28, 2023 |
By: |
/s/ Tali Dinar |
|
|
Tali Dinar |
|
|
Chief Financial Officer |
3
Exhibit 99.1
Medigus
to Acquire 60% Interest of Commercial Property in Miami
The company intends to establish its presence
in Miami by acquiring, improving, renovating, developing and selling commercial properties.
Tel Aviv, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE)
-- Medigus Ltd. (Nasdaq: MDGS) (“Medigus” or the “Company”), a technology company engaged in innovative internet technologies, electric vehicle and charging solutions and advanced medical solutions, announced
today it has signed an operating agreement with a US-based partner specializing in acquiring, improving, renovating, developing and
selling commercial properties in Miami (the “Partner”) for the formation of a joint venture (“JV”), that will
purchase, renovate, manage and sell a commercial property in Miami, Florida, USA. The formation of the JV is contingent upon the property’s
acquisition by mid-October.
The property consists of 3 parcels containing
land of approximately 19,000 square feet which consists of a one 2-story building containing 9,000 square feet, and a one-story building
containing 2,800 square feet. The property has additional development rights, and subject to approvals and permits, could result in additional
stories.
The initial capital contribution paid by Medigus
is $2 million and its initial percentage interest in the JV is 60%, while the Partner interest is 40%. According to the operating agreement,
Medigus has full preference in the JV cash distribution, and once the initial contribution by Medigus has been fully repaid, Medigus’
interest in the JV will decrease to 30%.
Medigus intends to continue and explore additional
opportunities in Miami for the purpose of acquiring, improving, renovating, further developing and selling the properties, directly or
indirectly, through one or more of its subsidiaries.
According to PwC 2023 Emerging Trends in Real
Estate survey, Miami, FL is ranked first in U.S office property and U.S retail property to buy, hold and sell recommendations, in
addition to ranking second in U.S Industrial and Hotel properties to buy, hold and sell recommendations.
According to PropStream, Miami’s
population is growing while unemployment declines, real estate costs are rising alongside greater availability while more corporations
are relocating to Miami and bringing their employees with them.
About Medigus
Based in Israel,
Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, engaged in innovative internet
technologies, electric vehicle and charging solutions and advanced medical solutions. The Company’s affiliates in digital
commerce include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging
Robotics Ltd. and Revoltz Ltd. by way of Fuel Doctor Holdings, Inc., and ParaZero Technologies Ltd. are also part of the
Company’s portfolio of technology solution providers. Medigus’ affiliation in the medical solutions arena includes
ownership in Polyrizon Ltd. Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus’ advanced
technologies, please visit http://www.medigus.com/.
Cautionary Note Regarding Forward Looking
Statements
This press release contains forward-looking statements
within the meaning of the “safe harbor” provisions of the
Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,”
“anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates”
and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal
with future events and are based on Medigus’ current expectations,
they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially
from those described in or implied by the statements in this press release. For example, Medigus
uses forward looking statements when it discusses its intention to investigate further opportunities in the Miami market and when it refers
the expected acquisition of the property under the operating agreement and its potential prospects.
The forward-looking statements contained or implied
in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise
required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events
or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been
provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus
is not responsible for the contents of third-party websites.th
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From May 2024 to Jun 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Jun 2023 to Jun 2024